Pfizer-BioNTech Covid-19 Vaccine for young infants to Be Reviewed through FDA Advisers

because the FDA nears a decision on authorizing Pfizer's Covid-19 vaccine for little ones 5-11 years historic, public-fitness officials and pediatricians are sharing analysis with families to guarantee hesitant folks of the shot's protection. photo: John Locher/associated Press

experts advising the meals and Drug Administration are scheduled to fulfill Tuesday to trust endorsing the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for use in young children.

Their effective recommendation would doubtless soon result in an expansion of the U.S. vaccination campaign to thousands and thousands of younger children.